TP53 and breast cancer: Notably, we found that both lncRNAs were more abundant in tumours bearing mutant p53 (Supplementary Fig. 2f, g), indicating that TROLL-2 and TROLL-3 may be critical breast cancer progression markers in p53 mutant cases.